Evidence map›Paper›PMID 19223468›Full record

ArticleMolecular and cellular biology2009

Phosphorylation of human DNA ligase I regulates its interaction with replication factor C and its participation in DNA replication and DNA repair.

Sangeetha Vijayakumar, Barbara Dziegielewska, David S Levin, Wei Song, Jinhu Yin, Austin Yang, Yoshihiro Matsumoto, Vladimir P Bermudez, Jerard Hurwitz, Alan E Tomkinson

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. DNA ligases as therapeutic targets.Translational cancer research · 2013
    Article
  13. Article
  14. Article
  15. DNA ligase I, the replicative DNA ligase.Sub-cellular biochemistry · 2012
    Review
  16. Article
  17. Article
  18. Targeting abnormal DNA double strand break repair in cancer.Cellular and molecular life sciences : CMLS · 2010
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Sangeetha VijayakumarDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201-1509, USA.
Barbara Dziegielewska
David S Levin
Wei Song
Jinhu Yin
Austin Yang
Yoshihiro Matsumoto
Vladimir P Bermudez
Jerard Hurwitz
Alan E Tomkinson
University of Maryland, Baltimore · USMemorial Sloan Kettering Cancer Center · USFox Chase Cancer Center · USThe University of Texas Health Science Center at San Antonio · US

Funding

Transcription-Coupled & Replication-Associated Excision RepairP01CA092584 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI John A. Tainer · 2001 to 2026
$89.6M
Studies on Eukaryotic ReplicationR01GM034559 · NIGMS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI HURWITZ, JERARD · 1985 to 2011
$9.3M
ROLES OF DNA LIGASE I IN MAMMALIAN DNA METABOLISMR01GM057479 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI TOMKINSON, ALAN E · 2000 to 2017
$3.7M
STUDIES ON PROCARYOTIC AND EUCARYOTIC DNA REPLICATIONR37GM034559 · NIGMS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI HURWITZ, JERARD · 1986 to 1995
–
NCI NIH HHS CA92584NCI NIH HHS P01 CA092584NIGMS NIH HHS GM034559NIGMS NIH HHS GM57479NIGMS NIH HHS R01 GM034559NIGMS NIH HHS R01 GM057479
6 · The paper itself

Abstract

Human DNA ligase I (hLigI) participates in DNA replication and excision repair via an interaction with proliferating cell nuclear antigen (PCNA), a DNA sliding clamp. In addition, hLigI interacts with and is inhibited by replication factor C (RFC), the clamp loader complex that loads PCNA onto DNA. Here we show that a mutant version of hLigI, which mimics the hyperphosphorylated M-phase form of hLigI, does not interact with and is not inhibited by RFC, demonstrating that inhibition of ligation is dependent upon the interaction between hLigI and RFC. To examine the biological relevance of hLigI phosphorylation, we isolated derivatives of the hLigI-deficient cell line 46BR.1G1 that stably express mutant versions of hLigI in which four serine residues phosphorylated in vivo were replaced with either alanine or aspartic acid. The cell lines expressing the phosphorylation site mutants of hLigI exhibited a dramatic reduction in proliferation and DNA synthesis and were also hypersensitive to DNA damage. The dominant-negative effects of the hLigI phosphomutants on replication and repair are due to the activation of cellular senescence, presumably because of DNA damage arising from replication abnormalities. Thus, appropriate phosphorylation of hLigI is critical for its participation in DNA replication and repair.

Indexed as

DNA RepairDNA ReplicationCell LineCell ProliferationCellular SenescenceDNA Ligase ATPDNA LigasesHumansMutant ProteinsPhosphorylationReplication Protein CDNA Ligase ATPDNA LigasesLIG1 protein, humanMutant ProteinsReplication Protein C

Identifiers

PMID19223468
PMCPMC2663303
OpenAlexW2073701176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.